8 - Capital Markets & Transaction Experience

Capital Markets
&
Transaction Experience
BIOPHARMACEUTICALS
MEDTECH & DIAGNOSTICS
Cardiovascular Devices
Prosthetic Heart Valve
Peripheral Vascular Devices
Cardiovascular Monitoring & Diagnostic Devices
Cardiovascular Surgery
Cardiac Rhythm Management
Cardiovascular Prosthetic Devices
Interventional Cardiology
Cardiac Assist Devices
Wound Care Management
Hospital Supplies
Syringes and Needles
Disposable Hospital & Surgical Supplies
Drug Delivery Devices
Inhalation Systems
Needle Free Injections
Infusion Systems
Diabetes Care Devices
Insulin Delivery & Glucose Monitoring
Ophthalmic Devices
Cataract Surgery Devices
Ophthalmic Diagnostic Equipment
Refractive Surgery Devices
ENT Devices
Hearing Implants
Diagnostic Devices
Electrosurgical Devices
Dental Equipment & Accessories
Diagnostic Imaging & MRI Systems
C/T Systems & Mammography Equipment
X-Ray & Ultrasound Systems
Nuclear Imaging Equipment
Contrast Media Injectors
Bone Densitometry
Anesthesia and Respiratory Devices
Anesthesia Machines & Disposables
Respiratory Devices & Disposables
Sleep Apnea Diagnostic Systems
Healthcare IT
Medical Imaging Information Systems
Nephrology and Urology Devices
Renal Dialysis Equipment
Orthopedic Devices
Orthobiologics & Arthroscopy
Joint Reconstruction
Trauma Fixation
Orthopedic Prosthetics
Cranium Maxillofacial Fixation (CMF)
Spinal Surgery
Endoscopy Devices & instruments
Rigid & Flexible Endoscope
In Vitro Diagnostics
Genetic Testing
Clinical Chemistry
Hematology
Immuno Chemistry
Infectious Immunology
Histology And Cytology
Patient Monitoring
Multiparameter Patient Monitoring
Micro-Electromechanical Systems
Non-invasive Blood Pressure Monitors
Neurology Devices
Neurostimulation Devices
Interventional Neurology
CSF Management
Neurosurgical Products
Radiosurgery
Diabetic Nephropathy
Diabetic Retinopathy
Hypercholesterolemia
Oral Mucositis
Gout
Acute Lymphocytic Leukemia
Bone Metastasis
Brain Cancer
Breast Cancer
Cervical Cancer
Chronic Lymphocytic Leukemia
Endometrial Cancer
Ewing Sarcoma
Gastric Cancer
Gastrointestinal Stromal Tumors
Head And Neck Cancer
Hodgkin Lymphoma
Kidney Cancer
Liver Cancer
Malignant Mesothelioma
Medullary Thyroid Cancer
Melanoma
Multiple Myeloma
Non-Hodgkin Lymphoma
Non-Small Cell Lung Cancer
Ovarian Cancer
Pancreatic Cancer
Testicular Cancer
Thyroid Cancer
Age Related Macular Degeneration
Keratoconjunctivitis sicca (Dry Eye)
Retinal Vein Occlusion
Acute Respiratory Distress
Syndrome
Sepsis
Staphylococcal Infections
Acute Coronary Syndrome
Angina Pectoris
Atrial Fibrillation
Coronary Artery Disease (CAD)
Critical Limb Ischemia
Hypertension
Pulmonary Arterial Hypertension
Acute Pain
Anxiety Disorders
Chronic Pain
Dementia
Diabetic Neuropathy
Obsessive-Compulsive Disorder
Osteoarthritis Pain
Parkinson's Disease
Post-Traumatic Stress Disorder
Restless Legs Syndrome
Schizophrenia
Traumatic Brain Injury
Liver Cirrhosis
Childhood Enuresis
Growth Hormone Disorders
Hyperparathyroidism
Hyperthyroidism
Guillain-Barre Syndrome
Cytomegalovirus
Fungal Infections
Gram-Negative Bacterial Infections
H1N1 Infection
Herpes Zoster
HIV-1 Infection
Human Papillomavirus Infections
Staphylococcus Aureus (MRSA)
Healthios Experience
Medical Devices & Diagnostics
SYNCARDIA SYSTEMS, INC.
BRONCUS TECHNOLOGIES, INC.
CHEETAH MEDICAL LTD.
Has sold certain emphysema assets to

Has completed its $11,000,000
Series D financing
THE UNDERSIGNED ACTED AS ADVISOR

TO SYNCARDIA

Series B financing
THE UNDERSIGNED ACTED AS EXCLUSIVE
ADVISOR TO CHEETAH
THE UNDERSIGNED ACTED AS EXCULSIVE

ADVISOR TO BRONCUS
TRIREME MEDICAL, INC.

Has entered into an exclusive
distribution agreement with

ADVISOR TO TRIREME
PATHWAY MEDICAL
TECHNOLOGIES, INC.
NOVADAQ TECHNOLOGIES, INC.
Has completed multiple strategic

initiatives

sales and marketing initiatives
Has completed a review of various divestiture

and strategic financing alternatives
THE UNDERSIGNED HAS ACTED AS EXCLUSIVE

STRATEGIC ADVISOR TO BIOSPHERE

STRATEGIC ADVISOR TO PATHWAY

ADVISOR TO NOVADAQ
TRIREME MEDICAL, INC.
BIOSPHERE MEDICAL, INC.

Series D financing
ADVISOR TO TRIREME
Research. Investment Banking. Healthcare.
VERAX BIOMEDICAL, INC.
CLAROS DIAGNOSTICS, INC.
DEERAC FLUIDICS, INC.
Has been acquired by
Has entered a Worldwide

Commercialization Partnership with
THE UNDERSIGNED ACTED AS FINANCIAL

ADVISOR TO CLAROS DIAGNOSTICS

FINANCIAL ADVISOR TO DEERAC FLUIDICS

FIANCIAL ADVISOR TO VERAX BIOMEDICAL
BOSTON SCIENTIFIC, INC.
INNFOCUS, LLC
Has completed a strategic review of its

endoscopy business unit leading to its
decision to optimize strategic alternatives
through a tax-efficient spin-off
Has completed a structured financing with
THE UNDERSIGNED ACTED AS STRATEGIC

ADVISOR TO CLAYTON DUBILIER & RICE

FINANCIAL ADVISOR TO INNFOCUS
CARDIOSOUTIONS, INC.
Series B financing led by

FINANCIAL ADVISOR TO CARDIOSOLUTIONS
BRONCUS TECHNOLOGIES, INC.

NEOCHORD, INC.
Has completed its

Series A financing

ADVISOR TO NEOCHORD

FINANCIAL ADVISOR TO BRONCUS
CLEARCOUNT MEDICAL
SOLUTIONS, INC.
VENTUS MEDICAL, INC.
Has licensed various IP to

ADVISOR TO CLEARCOUNT MEDICAL SOLUTIONS

ADVISOR TO VENTUS MEDICAL
EXAGEN DIAGNOSTICS, INC.
NANOMIX, INC.

Debt financing

Equity financing by strategic and
financial investors

ADVISOR TO EXAGEN DIAGNOSTICS

ADVISOR TO NANOMIX
CRITICAL PERFUSION, INC.
MIACOM DIAGNOSTICS
Has entered into a co-development

agreement with
Has completed its equity financing from
BIOMERIX, INC.
Has completed a
Strategic Investment by


STRATEGIC ADVISOR TO BIOMERIX

BioPharmaceuticals
INSPIRATION
BIOPHARMACEUTICALS, INC.
Completed a strategic partnership with
NOVALAR PHARMACEUTICALS, INC.

LIQUIDIA TECHNOLOGIES, INC.

Has completed a global collaboration
with
SORBENT THERAPEUTICS, INC.

Has completed its spinout from
Dow Chemical
$65,000,000
$259,000,000
FINANCIAL ADVISOR TO INSPIRATION

FINANCIAL ADVISOR TO NOVALAR

ADVISOR TO LIQUIDIA

ADVISOR TO SORBENT
ALPHA THERAPEUTICS, INC
BAYER PLASMA, GmBH
An operating division of
CORIUM INTERNATIONAL, INC.
PINNACLE BIOLOGICS, INC.

Series A financing
FINANCIAL ADVISOR TO PINNACLE

ADVISOR TO MORGAN STANLEY
Has issued $35 million in

Interest-Bearing High Yield Securities

ADVISOR TO CORIUM INTERNATIONAL

Cerberus, LLC
BioPharmaceuticals
DICERNA PHARMACEUTICALS, INC.
ENVISIA THERAPEUTICS, INC.

Series C Financing
Has completed a $25 ,000,000

Series A Financing in conjunction
with the spin off of certain assets
and sciences from Liquidia

ADVISOR TO DICERNA

ADVISOR TO LIQUIDIA
IRX Therapeutics
FDBU (a Fujifilm subsidiary) acquires

49% of the total membership interests in
Kalon

ADVISOR TO KALON
CORIUM INTERNATIONAL, INC.,
Has completed a round of financing
$52,000,000
Initial Public Offering
THE UNDERSIGNED ACTED AS ADVISOR

TO IRX

ADVISOR TO CORIUM
Diabetes Management
CALIBRA MEDICAL, INC.

Has issued $10,000,000
STEADYMED, LTD
CALIBRA MEDICAL, INC.

Senior Subordinated Debt
Series B Preferred Stock

FINANCIAL ADVISOR TO CALIBRA

FINANCIAL ADVISOR TO CALIBRA

FINANCIAL ADVISOR TO STEADYMED
WELLDOC, INC.
BAXTER INTERNATIONAL, INC.
ING BARING
Has completed a strategic partnership

with

ADVISOR TO WELLDOC
Has completed an investment in
Has completed a strategic review of its

dialysis business unit, including a market
study of the Wearable Kidney Market and
the Chronic Kidney Disease Market

ADVISOR TO ING BARING

ADVISOR TO BAXTER
WELLDOC, INC.
Series A Preferred Stock

ADVISOR WELLDOC
Digital Health
EPOCRATES, INC.
iMEDICA, INC
with
WELLDOC, INC.

initiatives

ADVISOR TO EPOCRATES

ADVISOR TO WELLDOC

ADVISOR TO iMEDICA
SXC HEALTH SOLUTIONS, INC.

Has expanded its management team and
Board of Directors with the addition of
several leaders with significant experience
in the global healthcare industry
ADVISOR TO SXC HEALTH SOLUTIONS
WELLDOC, INC.
with
PULSE SYSTEMS
ADVANTEDGE HEALTH SOLUTIONS
Healthios has issued a fairness

opinion in conjunction with the
acquisition of Pulse Systems

initiatives
ADVISOR TO WELLDOC

ADVISOR TO AHS

ADVISOR TO PULSE
INLIGHT, INC.
Has issued
$39,000,000
PARTNERS OF THE UNDERSIGNED ACTED AS
PRINCIPALS TO INLIGHT
Medical Surgical Products & Distribution
QUANTUM OPS, LLC

Has entered into an exclusive distribution
agreement with

FINANCIAL ADVISOR TO QUANTUM OPS
SMARTPILL, INC.

FINANCIAL ADVISOR TO SMARTPILL
REGENT MEDICAL, PLC
MOLNLYCKE HEALTHCARE, AG


ADVISOR TO CLAYTON DUBILIER & RICE
ALINE
AESTHETICS
ORTHOCON, INC.
a wholly owned subsidiary of
Has completed a comprehensive

review of strategic & financial
alternatives

ADVISOR TO ORTHOCON

ADVISOR TO ALINE AESTHETICS
ING BARING
Has completed an investment in

ADVISOR TO ING BARING
Renal
RMS LIFELINE, INC
SORBENT THERAPEUTICS, INC.

DOW CHEMICAL, INC

Through the spin off of certain
assets and sciences, and through the
contribution of $20 million of capital
from leading institutions, has formed
Through the divestiture of certain assets

and the completion of a long-term
product supply agreement, has formed

ADVISOR TO DOW CHEMICAL

ADVISOR TO METALMARK CAPITAL
FRESENIUS MEDICAL CARE

ADVISOR TO SORBENT

ADVISOR TO J.W. CHILDS
10
Healthcare Services
WELLFOUNT CORP.
Has completed its $22,000,000 Debt
and Equity financing

ADVISOR TO WELLFOUNT
APOLLO HOSPITAL GROUP INDIA

A portfolio investment of
UPSTREAM REHABILITATION, LLC
OSF HEALTHCARE
Has appointed the senior management of
Has been formed by management

in collaboration with
Has expanded its management team and

Board of Directors with the addition of
several leaders with significant experience
in the global healthcare industry

ADVISOR TO ONE EQUITY PARTNERS

ADVISOR TO UPSTREAM REHABILITATION

ADVISOR TO OSF HEALTHCARE
NCS HEALTHCARE, INC.


ADVISOR TO PALADIUM EQUITY PARTNERS
11

8 - Capital Markets & Transaction Experience

Загружено:

Сведения о документе

Исходное описание:

Оригинальное название

Авторское право

Доступные форматы

Поделиться этим документом

Поделиться или встроить документ

Параметры публикации

Этот документ был вам полезен?

Это неприемлемый материал?

Авторское право:

Доступные форматы

8 - Capital Markets & Transaction Experience

Загружено:

Авторское право:

Доступные форматы

Capital Markets

MEDTECH & DIAGNOSTICS

SYNCARDIA SYSTEMS, INC.

BRONCUS TECHNOLOGIES, INC.

CHEETAH MEDICAL LTD.

Has sold certain emphysema assets to

THE UNDERSIGNED ACTED AS ADVISOR

Has completed its $20,000,000

THE UNDERSIGNED ACTED AS EXCULSIVE

TRIREME MEDICAL, INC.

THE UNDERSIGNED ACTED AS EXCLUSIVE

NOVADAQ TECHNOLOGIES, INC.

Has completed multiple strategic

Has completed multiple strategic

Has completed a review of various divestiture

THE UNDERSIGNED HAS ACTED AS EXCLUSIVE

THE UNDERSIGNED HAS ACTED AS EXCLUSIVE

THE UNDERSIGNED ACTED AS EXCLUSIVE

TRIREME MEDICAL, INC.

BIOSPHERE MEDICAL, INC.

Has completed its $17,000,000

Research. Investment Banking. Healthcare.

VERAX BIOMEDICAL, INC.

CLAROS DIAGNOSTICS, INC.

DEERAC FLUIDICS, INC.

Has been acquired by

Has been acquired by

Has entered a Worldwide

THE UNDERSIGNED ACTED AS FINANCIAL

THE UNDERSIGNED ACTED AS EXCLUSIVE

THE UNDERSIGNED ACTED AS EXCLUSIVE

BOSTON SCIENTIFIC, INC.

Has completed a strategic review of its

Has completed a structured financing with

THE UNDERSIGNED ACTED AS STRATEGIC

THE UNDERSIGNED ACTED AS EXCULSIVE

THE UNDERSIGNED ACTED AS EXCLUSIVE

BRONCUS TECHNOLOGIES, INC.

Has been acquired by

Has completed its

Research. Investment Banking. Healthcare.

THE UNDERSIGNED ACTED AS FINANCIAL

THE UNDERSIGNED ACTED AS EXCULSIVE

VENTUS MEDICAL, INC.

Has licensed various IP to

Has been acquired by

THE UNDERSIGNED ACTED AS EXCLUSIVE

THE UNDERSIGNED ACTED AS EXCLUSIVE

EXAGEN DIAGNOSTICS, INC.

Has completed its $25,000,000

Has completed its $12,000,000

THE UNDERSIGNED ACTED AS EXCLUSIVE

THE UNDERSIGNED ACTED AS EXCLUSIVE

CRITICAL PERFUSION, INC.

Has entered into a co-development

Has completed its equity financing from

THE UNDERSIGNED ACTED AS EXCLUSIVE

THE UNDERSIGNED HAS ACTED AS EXCLUSIVE

THE UNDERSIGNED ACTED AS EXCLUSIVE

Research. Investment Banking. Healthcare.

NOVALAR PHARMACEUTICALS, INC.

LIQUIDIA TECHNOLOGIES, INC.